Literature DB >> 34671810

Elevated C-Reactive Protein in Alzheimer's Disease Without Depression in Older Adults: Findings From the Health and Retirement Study.

Ginny Natale1, Sean A P Clouston1, Dylan M Smith1.   

Abstract

We examined the association between differential diagnoses of major stroke and probable Alzheimer's disease (AD) and mixed AD on C-reactive protein (CRP) in older adults with and without depression. Secondary data analyses examined associations between blood-based measures of probable peripheral inflammation using CRP collected from dried blood spots in the Health and Retirement Study, a nationally representative sample of individuals aged 50 and older. A validated pattern-recognition algorithm was utilized to identify cognitive decline indicative of probable AD, mixed AD, and major stroke. Negative binomial regressions were utilized to model concentrations of serologic CRP. On average, participants (N = 4 601) were 70 years old, female, and non-Hispanic White. Mixed AD participants had a 0.26 mg/dL increase in CRP compared to unimpaired participants, controlling for demographics, health behaviors, and comorbidities. Those with mixed AD had 2.14 times increased odds of having high CRP (odds ratio = 2.14 [1.19-3.85]). In analyses stratified by depression, adults with mixed AD and without depression had an additional 0.37 mg/dL increase in CRP (SE = 0.06; p < .001) compared to unimpaired adults. Those with AD without depression had a 0.20 mg/dL increase in CRP (SE = 0.07; p < .01). Age was not associated with increased CRP in nondepressed older adults. Depressed adults with major stroke had a -0.26 mg/dL decrease in CRP (SE = 0.11; p = .02), controlling for hypertension, alcoholic drinks/beverages per week, and smoking status. Concentration modeling revealed that participants with major stroke, probable AD, and probable mixed AD without depression had significantly higher CRP concentrations when compared to unimpaired older adults. Published by Oxford University Press on behalf of The Gerontological Society of America 2021.

Entities:  

Keywords:  Alzheimer’s disease; C-reactive protein; Dementia; Depression; Inflammation; Major stroke

Mesh:

Substances:

Year:  2022        PMID: 34671810      PMCID: PMC8974321          DOI: 10.1093/gerona/glab282

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.591


  69 in total

1.  Validation of blood-based assays using dried blood spots for use in large population studies.

Authors:  Eileen Crimmins; Jung Ki Kim; Heather McCreath; Jessica Faul; David Weir; Teresa Seeman
Journal:  Biodemography Soc Biol       Date:  2014

2.  Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression.

Authors:  Ole Köhler-Forsberg; Henriette N Buttenschøn; Katherine E Tansey; Wolfgang Maier; Joanna Hauser; Mojca Zvezdana Dernovsek; Neven Henigsberg; Daniel Souery; Anne Farmer; Marcella Rietschel; Peter McGuffin; Katherine J Aitchison; Rudolf Uher; Ole Mors
Journal:  Brain Behav Immun       Date:  2017-03-01       Impact factor: 7.217

3.  Association Between Low-Grade Systemic Inflammation and Type 2 Diabetes Mellitus Among Men and Women from the ATTICA Study.

Authors:  Christos Pitsavos; Metaxia Tampourlou; Demosthenes B Panagiotakos; Yannis Skoumas; Christina Chrysohoou; Tzortzis Nomikos; Christodoulos Stefanadis
Journal:  Rev Diabet Stud       Date:  2007-08-10

4.  Serum high sensitivity C-reactive protein and cognitive function in elderly women.

Authors:  Pirjo Komulainen; Timo A Lakka; Miia Kivipelto; Maija Hassinen; Ilkka M Penttilä; Eeva-Liisa Helkala; Helena Gylling; Aulikki Nissinen; Rainer Rauramaa
Journal:  Age Ageing       Date:  2007-05-30       Impact factor: 10.668

5.  Dried blood spots--preparing and processing for use in immunoassays and in molecular techniques.

Authors:  Nico Grüner; Oumaima Stambouli; R Stefan Ross
Journal:  J Vis Exp       Date:  2015-03-13       Impact factor: 1.355

6.  Ten-year alcohol consumption typologies and trajectories of C-reactive protein, interleukin-6 and interleukin-1 receptor antagonist over the following 12 years: a prospective cohort study.

Authors:  S Bell; G Mehta; K Moore; A Britton
Journal:  J Intern Med       Date:  2016-08-03       Impact factor: 8.989

Review 7.  Glial contributions to neurodegeneration in tauopathies.

Authors:  Cheryl E G Leyns; David M Holtzman
Journal:  Mol Neurodegener       Date:  2017-06-29       Impact factor: 14.195

Review 8.  Alzheimer's disease: A matter of blood-brain barrier dysfunction?

Authors:  Axel Montagne; Zhen Zhao; Berislav V Zlokovic
Journal:  J Exp Med       Date:  2017-10-23       Impact factor: 14.307

9.  Role of Microglial Cells in Alzheimer's Disease Tau Propagation.

Authors:  Ena Španić; Lea Langer Horvat; Patrick R Hof; Goran Šimić
Journal:  Front Aging Neurosci       Date:  2019-10-04       Impact factor: 5.750

Review 10.  Alzheimer's Disease: Exploring the Role of Inflammation and Implications for Treatment.

Authors:  Mark E McCaulley; Kira A Grush
Journal:  Int J Alzheimers Dis       Date:  2015-11-17
View more
  1 in total

1.  Transcranial Electromagnetic Treatment Stops Alzheimer's Disease Cognitive Decline over a 2½-Year Period: A Pilot Study.

Authors:  Gary Arendash; Haitham Abulaban; Susan Steen; Ross Andel; Yanhong Wang; Yun Bai; Rob Baranowski; Jon McGarity; Lyle Scritsmier; Xiaoyang Lin; Ning Shen; Ali Aljassabi; Yitong Li; Chuanhai Cao
Journal:  Medicines (Basel)       Date:  2022-08-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.